new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Amgen Inc patents

Recent patent applications related to Amgen Inc. Amgen Inc is listed as an Agent/Assignee. Note: Amgen Inc may have other listings under different names/spellings. We're not affiliated with Amgen Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Amgen Inc-related inventors




Date Amgen Inc patents (updated weekly) - BOOKMARK this page
03/23/17Interleukin-2 muteins for the expansion of t-regulatory cells
03/23/17Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
03/23/17Method of modulating fibroblast accumulation or collagen deposition
03/23/17Assay for detecting th1 and th2 cell populations
03/16/17Drug delivery device
03/16/17Anti-activin a antibodies and uses thereof
03/09/17Proteins specific for baff and b7rp1
02/23/17Pharmaceutical formulations
02/16/17Triazole agonists of the apj receptor
02/16/17Triazole agonists of the apj receptor
02/16/17Triazole agonists of the apj receptor
02/16/17Triazole agonists of the apj receptor
02/09/17Triazole agonists of the apj receptor
02/09/17Triazole agonists of the apj receptor
02/02/17Antibody constructs for msln and cd3
02/02/17Polymorphic forms and co-crystals of a c-met inhibitor
01/26/17Gitr antigen binding proteins
01/19/17Anti-erythropoietin antibodies
01/19/17Human antigen binding proteins that bind betta-klotho, fgf receptors and complexes thereof
01/05/17Human il-23 antigen binding proteins
01/05/17St2 antigen binding proteins
12/29/16Methods and apparati for nondestructive detection of undissolved particles in a fluid
12/29/16Methods and apparati for nondestructive detection of undissolved particles in a fluid
12/29/16Methods and apparati for nondestructive detection of undissolved particles in a fluid
12/22/16Self-buffering protein formulations
12/22/16Self-buffering protein formulations
12/22/16Fused tricyclic dual inhibitors of cdk 4/6 and flt3
12/15/16Self-buffering protein formulations
12/15/16Self-buffering protein formulations
12/15/16Self-buffering protein formulations
12/08/16Drug delivery system with temperature-sensitive control
12/01/16Method for the preparation of [1,2,4]-triazolo[4,3-a]pyridines
11/24/16Self-buffering protein formulations
11/24/16Triazole agonists of the apj receptor
11/24/16Human c-fms antigen binding proteins
11/24/16Anti-mesothelin binding proteins
11/24/16Rapid dissolution formulation of a calcium receptor-active compound
11/17/16Heterocyclic compounds and their uses
11/17/16Regulating orinthine metabolism to manipulate the high mannose glycoform content of recombinant proteins
11/03/16Combination of epigenetic factors and bispecific compounds targeting cd33 and cd3 in the treatment of myeloid leukemia
11/03/16Self-buffering protein formulations
10/27/16Methods for treating or preventing migraine headache
10/20/16Crystalline forms of n-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl -2-thienyl)-1-phthalazinamine salts and uses thereof
10/20/16Potent and selective inhibitors of nav1.3 and nav1.7
10/20/16Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
10/20/16Methods for modulating mannose content of recombinant proteins
10/13/16Injector and assembly
10/13/16Flocculation method
10/06/16Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
10/06/16Processes of making and crystalline forms of a mdm2 inhibitor
10/06/16Processes of making and crystalline forms of a mdm2 inhibitor
10/06/16Processes of making and crystalline forms of a mdm2 inhibitor
10/06/16Processes of making and crystalline forms of a mdm2 inhibitor
09/29/16Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/29/16Heteroaryloxycarbocyclyl compounds as pde 10 inhibitors
09/29/16Use of monensin to regulate glycosylation of recombinant proteins
09/15/16Processes of making and crystalline forms of a mdm2 inhibitor
09/15/16Variant activin receptor
09/08/16V-c-fc-v-c antibody
09/01/16Human pac1 antibodies
08/25/16Fgf21 mutants and uses thereof
08/18/16High concentration antibody formulations
08/18/16Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
08/04/16Stable liquid formulation of amg 416 (velcalcetide)
08/04/16Production of glycoproteins using manganese
Patent Packs
08/04/16High titer recombinant aav vector production in adherent and suspension cells
08/04/16Material and methods for treating or preventing her-3 associated diseases
07/21/16Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
07/21/16Il-17ra-il-17rb antagonists and uses thereof
07/14/16Drug delivery device
07/14/16Injector and assembly
07/14/16Method of assembling and filling a drug delivery device
07/14/16Method of assembling and filling a drug delivery device
07/07/16Stabilization of fc-containing polypeptides
06/23/16Drug delivery device with proximity sensor
06/23/16Drug delivery device with proximity sensor
06/23/16Azetidine and piperidine compounds useful as pde10 inhibitors
06/23/16Peptides and related molecules that bind to tall-1
06/23/16Methods and compositions relating to anti-il-21 receptor antibodies
06/16/16Drug delivery device
Patent Packs
06/16/16Injector and assembly
06/16/16Growth differentiation factor 15 (gdf-15) constructs
06/16/16Fgf mutants and uses thereof
06/16/16Binding agents
06/16/16Antibodies directed to her-3 and uses thereof
06/09/16Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
06/09/16Il-17 receptor a is required for il-17c biology
06/02/16Novel activin receptor and uses thereof
06/02/16Antigen binding proteins capable of binding thymic stromal lymphopoietin
05/26/16Lyophilized therapeutic peptibody formulations
05/26/16Cb-1 receptor antigen-binding proteins and uses thereof
05/26/16Bispecific-fc molecules
05/26/16Human anti-b7rp1 neutralizing antibodies
05/26/16Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof
05/19/16Bicyclic sulfonamide compounds as sodium channel inhibitors
05/19/16Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
05/19/16Il-1 family variants
05/19/16Stabilized receptor polypeptides and uses thereof
04/28/16Heterodimeric bispecific antibodies
04/14/16Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
03/24/16Pre-filled syringe identification tag
03/24/16Sclerostin antibody crystals and formulations thereof
03/24/16Ferroportin antibodies and methods of use
03/10/16Apj receptor agonists and uses thereof
03/10/16Compounds that inhibit mcl-1 protein
03/03/16Methods for treating psoriasis using an anti-il-23 antibody
03/03/16Feed media
02/25/16Apelin antigen-binding proteins and uses thereof
02/18/16Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
02/18/16Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
Social Network Patent Pack
02/18/16Bicyclic sulfonamide compounds as sodium channel inhibitors
02/18/16Heterodimeric immunoglobulins
02/18/16Methods of treatment using an interferon gamma inhibitor
02/11/16Myostatin antagonism in human subjects
02/11/16Body contour adaptable autoinjector device
02/11/16Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer
02/11/16Human pac1 antibodies
02/11/16Human cd30 ligand antigen binding proteins
02/11/16Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
02/11/16Method for culturing mammalian cells to improve recombinant protein production
Patent Packs
02/04/16Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
02/04/16Methods for treating crohn's disease using an anti-il23 antibody
02/04/16Methods and compositions relating to anti-ccr7 antigen binding proteins
02/04/16Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
02/04/16Antibody constructs for cdh19 and cd3
02/04/16Methods for increasing mannose content of recombinant proteins
01/28/16Potent and selective inhibitors of nav1.7
01/28/16Drug cassette, autoinjector, and autoinjector system
01/28/16Removal of leaked affinity purification ligand
01/28/16Inhibitory polypeptides specific to wnt inhibitors
01/28/16Potent and selective inhibitors of nav1.7
01/28/16Secreted frizzle-related protein 5 (sfrp5) binding proteins and methods of treatment
01/28/16Proteins specific for baff and b7rp1 and uses thereof
01/28/16Protein formulations
01/21/16Heterocyclic compounds and their uses
01/21/16Salt of omecamtiv mecarbil and process for preparing salt
01/14/16Method of treating metabolic disorders using pla2g12a polypeptides and pla2g12a mutant polypeptides
01/14/16Heparin-binding epidermal growth factor-like growth factor binding proteins
01/07/16Modified fc molecules
01/07/16Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
12/31/15Injector and assembly
12/31/15Carbohydrate phosphonate derivatives as modulators of glycosylation
12/31/15Human cgrp receptor binding proteins
12/24/15Antibody constructs for cdh19 and cd3
12/17/15Administration of an anti-activin-a compound to a subject
12/17/15Capture purification processes for proteins expressed in a non-mammalian system
12/10/15Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
12/03/15Btnl9 proteins, nucleic acids, and antibodies and uses thereof
12/03/15Bcma antigen binding proteins
11/26/15Pharmaceutical compositions
Patent Packs
11/19/15Amides as pim inhibitors
11/19/15Refolding proteins using a chemically controlled redox state
11/12/15Antibodies that bind myostatin, compositions and methods
11/12/15Antibodies targeting cdh19 for melanoma
11/05/15Refolding proteins using a chemically controlled redox state
11/05/15Formulations
10/29/15Glycine transporter-1 inhibitors
10/29/15Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
10/29/15Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
10/22/15Crystalline forms of (1s)-1-[5-(amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diol
10/15/15Drug delivery device
10/08/15Human lcat antigen binding proteins and their use in therapy
10/01/15Method for inhibiting bone resorption
10/01/15Compositions and methods relating to anti-igf-1 receptor antibodies
09/24/15Pyrazole amide derivative
09/24/15Antibodies to opgl
09/17/15Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
09/17/15Autoinjector
09/10/15Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/10/15Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
Social Network Patent Pack
08/20/15Carrier immunoglobulins and uses thereof
08/20/15Variant activin receptor polypeptides and uses thereof
08/20/15Carrier immunoglobulins and uses thereof
08/13/15Quinazolinone compounds and derivatives thereof
08/06/15Cd27l antigen binding proteins
07/23/15Autologous mammalian models derived from induced pluripotent stem cells and related methods
07/23/15Method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
06/25/15Myostatin binding agents
06/18/15Btnl3 proteins, nucleic acids, and antibodies and uses thereof
06/04/15Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
06/04/15Dual receptor antagonistic antigen-binding proteins and uses thereof
05/21/15Method for the preparation of thiadiazoles
03/26/15Anti-activin a antibodies and uses thereof
03/26/15Alpha-4-beta-7 heterodimer specific antagonist antibody
03/26/15Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
03/19/15Use of amg 900 for the treatment of cancer
03/05/15Gitr antigen binding proteins
02/26/15Methods of determining exposure to uv light
02/26/15Dr5 receptor agonist combinations
02/26/15Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
Social Network Patent Pack
02/26/15Heparin-binding epidermal growth factor-like growth factor binding proteins
02/12/15Carrier immunoglobulins
02/12/15Carrier immunoglobulins
02/12/15Heterocyclic compounds and their uses
02/12/15Oxazolidinone compounds and derivatives thereof
02/12/15Autoinjector apparatus
02/05/15Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
01/29/15Chroman derivatives as trpm8 inhibitors
01/29/15Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
01/22/15Potent and selective inhibitors of nav1.7
01/22/15Thrombopoietic compounds
01/15/15Il-1 family variants
01/15/15Sulfamide sodium channel inhibitors
01/08/15Human pac1 antibodies
01/01/15Methods for treating homozygous familial hypercholesterolemia
01/01/15Flocculation method
12/25/14Growth differentiation factor 15 (gdf-15) polypeptides
12/18/14Bicyclic sulfonamide compounds as sodium channel inhibitors
12/18/14Igg2 disulfide isoform separation
12/04/14Methods for increasing mannose content of recombinant proteins
11/27/14Predictive biomarker of survival in the treatment of renal cell carcinoma
11/20/14Interleukin-2 muteins for the expansion of t-regulatory cells
10/30/14Administration of alpha4beta7 hetero- dimer-specific antibody
10/30/14Pharmaceutical composition for the treatment of type-1 diabetes
10/30/14Il-17ra-il-17rb antagonists and uses thereof
10/30/14Fgf21 mutants and uses thereof
10/23/14Methods of treating epidermal growth factor deletion mutant viii related disorders
10/23/14Pharmaceutical product and analysing light exposure of a pharmaceutical product
10/16/14Heterodimeric bispecific antibodies
10/16/14Heterocyclic compounds and their uses
Social Network Patent Pack
10/09/14Proteins specific for baff and b7rp1
10/09/14Bispecific-fc molecules
10/02/14Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
10/02/14Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
10/02/14Pre-programmed non-feedback controlled continuous feeding of cell cultures
09/25/14Interleukin-2 muteins for the expansion of t-regulatory cells
09/25/14Hepcidin, hepcidin antagonists and methods of use
09/25/14Modified lecithin-cholesterol acyltransferase enzymes
09/25/14Injector and assembly
09/18/14Methods for treating bone gap defects
09/18/14Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
09/18/14Specific binding agents of human angiopoeitin-2
09/18/14Fibroblast growth factor receptor-like molecules and uses thereof
09/11/14Mammalian cell culture
09/11/14Polypeptides involved in immune response
09/11/14Heteroaryl sodium channel inhibitors
09/04/14Epitopes
08/28/14Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
08/28/14Benzoic acid derivative mdm2 inhibitor for the treatment of cancer
08/28/14Fgf21 mutants and uses thereof
08/21/14Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patients
08/21/14Il-17 receptor a is required for il-17c biology
08/21/14Peptides and related molecules that bind to tall-1
08/21/14Transthyretin variants
08/21/14Trpm8 antagonists and their use in treatments
08/21/14Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
08/21/14Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
08/14/14Method of treating or ameliorating metabolic disorders using clec-2
08/14/14Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amgen Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amgen Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';